Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Texas for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Texas only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Texas (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Antonio Aragon (NPI 1992774590)

Field	Value
Entity Type	Individual
Organization	Antonio Aragon
Address	7411 Wallace Blvd
City	Amarillo
State	TX
ZIP	79106
Taxonomy	Ophthalmology Physician
NPI Enumerated	March 16, 2006

Payer Source	Total Paid
Medicare	$7.3M
Medicaid	$0

Key Findings

This provider is effectively single-payer in scope: total Medicare revenue is $7.3M while there is no Medicaid billing on file ("none below"), indicating the practice’s Medicare business dominates its public-payer mix and patient population. The absence of Medicaid claims suggests limited exposure to low-income or non-Medicare populations through state programs and may affect contracting and network leverage with payers that emphasize dual-eligibles or Medicaid populations.

Revenue is highly concentrated: the precomputed top 3 codes (J2777, J3490, 99214) account for 77.6% of this provider's total Medicare revenue. Those three codes individually include J2777 with $3.9M (52.9% of Medicare revenue), J3490 with $1.4M (19.6%), and 99214 with $375.4K (5.1%), which together create a concentration risk if utilization or coverage of these services changes.

The code mix identifies a high-volume retinal/intravitreal injection practice supported by intensive diagnostics: J2777 (faricimab) shows 133.4K claims and $3.9M revenue, and other intravitreal drugs and injection codes (J2781, J2778, J0178, J9035, and 67028) appear throughout the top codes. Diagnostic angiography and imaging are also prominent — 92235 has 3.1K claims and $312.8K and 92134 shows 4.2K claims and $123.1K — indicating the practice pairs frequent drug administration with multimodal retinal imaging and interpretation.

Several codes show national standing as outliers, signaling this provider operates at unusually high volume for specific retinal services: J2777 ranks #9 of 2039 providers nationally (100th percentile; extreme outlier), 92235 ranks #2 of 2192 (100th percentile; extreme outlier), and 99214 ranks #51 of 479517 (100th percentile; extreme outlier). By contrast, J3490 ranks #54 of 2838 (98th percentile; typical, unremarkable volume) and some drug codes like J0178 rank lower (2632 of 3204, 18th percentile), illustrating that dominance is concentrated in a few specific products and services rather than across all drug codes.

Operational intensity is reflected in outpatient visit and procedure volumes: 99214 appears with 4.2K claims at $89 avg paid/claim and $375.4K revenue (5.1% of Medicare revenue), while procedural injection codes such as 67028 show 3.6K claims and $304K revenue (4.2%). This mix of frequent moderate-complexity E/M visits plus large counts of injection procedures is consistent with a practice model that schedules regular follow-up visits tied to serial intravitreal therapy.

Although injections and imaging dominate, there is evidence of surgical retina capability at lower volumes: 67042 reports 37 claims and $31.5K revenue and 67036 reports 27 claims and $16.3K revenue, indicating occasional vitreoretinal surgeries. These surgical codes are present but do not materially drive revenue compared with the dominant drug and imaging codes, suggesting surgery is a secondary line of service rather than the primary revenue engine.

The provider’s tenure suggests an established practice footprint: NPI enumeration date is 2006-03-16 (~20 years ago), which aligns with sustained Medicare billing patterns and the development of high-volume service lines over time. Long tenure combined with extreme-outlier volumes on select codes implies organizational experience in retinal drug delivery and related imaging that likely supports current high utilization.

From a competitive and contracting perspective, this profile identifies a clinician who is a national high-volume outlier on a narrow set of retinal drug and imaging codes, making the practice a major player for faricimab administration (J2777) and related diagnostics regionally and nationally. Payers and network managers should note the concentration around a few drugs and services (77.6% from the top three codes) when modeling reimbursement risk, formulary impacts, or negotiating site-of-care policies for intravitreal therapies.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

27 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J2777	Injection, faricimab‑svoa, 0.1 mg	133,380	$30	$3.9M
J3490	Unclassified drugs	820	$1,740	$1.4M
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	4,220	$90	$375.4K
92235	The provider uses a special dye, fluorescein that causes the blood vessels in the one or both eyes to stand out in photographic images taken with the use of multiframe timing, or serial images, taken…	3,100	$100	$312.8K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	3,580	$90	$304K
J2778	Injection, ranibizumab, 0.1 mg	1,230	$180	$221.9K
92240	The provider uses a special dye, indocyanine–green (ICG), to take photographs of the vessels of the inner eye similar to that done for codes 92230/92235, which use fluorescein dye. He interprets the…	1,070	$140	$151.4K
J0178	Injection, aflibercept, 1 mg	190	$680	$128.4K
J2781	Injection, pegcetacoplan, intravitreal, 1 mg	1,070	$120	$127.8K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	4,240	$30	$123.1K

Showing 1–10 of 27

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 27 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Texas Distribution

Antonio Aragon — 8 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Texas

Full comparison — all codes billed, vs. state median

27 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	175	210	610	$690	$694.9K
J2777	4	140	7,470	$30	$479.2K
J2778	31	80	630	$180	$345.3K
J2781	17	50	720	$120	$131.9K
67028	6	290	510	$90	$73K
92240	2	10	230	$140	$66.9K
J3490	7	350	60	$480	$54.4K
67042	22	90	20	$1,150	$41.3K
67113	18	30	20	$1,230	$29.4K
67036	18	70	20	$1,000	$29.1K

Showing 1–10 of 27

Related Providers

Other providers that share a Tax Identification Number (TIN) with Antonio Aragon, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Jason Ysasaga	TX	Ophthalmology Physician	$9.9M	$0
Ryan Rush	TX	Ophthalmology Physician	$9.7M	$0
Christopher Fisher	OK	Internal Medicine Physician	$7.6M	$0
Brian Phelps	OK	Retina Specialist (Ophthalmology) Physician	$4.1M	$0
Christopher Fuller	TX	Ophthalmology Physician	$3.6M	$0
Constantine Saadeh	TX	Rheumatology Physician	$3.6M	$0
Michael Hood	OK	Retina Specialist (Ophthalmology) Physician	$3.5M	$0
Jim Lu	IL	Anatomic Pathology Physician	$2.7M	$584.1K
Ashok Reddy	NM	Ophthalmology Physician	$3.2M	$0
Joseph Wolcott	TX	Undersea and Hyperbaric Medicine (Preventive Medicine) Physician	$3.1M	$0

Nearby Providers

Other providers in the same ZIP code as Antonio Aragon, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Northwest Texas Healthcare System Inc	TX	General Acute Care Hospital	$0	$44.8M
Amarillo Independent School District	TX	Local Education Agency (LEA)	$0	$17.5M
Epic Health Services, Inc.	TX	Home Health Agency	$0	$13.8M
Britkare Home Medical Of Texas Ltd	TX	Durable Medical Equipment & Medical Supplies	$0	$12.6M
Texas Panhandle Mental Health Mental Retardation	TX	Intellectual and/or Developmental Disabilities Community Based Residential Treatment Facility	$0	$11.6M
Apc-amarillo Surgical Operating Company, LLC	TX	Ambulatory Surgical Clinic/Center	$4.8M	$380
Amarillo Cataract And Eye Surgery Center Ltd	TX	Ophthalmologic Surgery Clinic/Center	$3.8M	$77.7K
Janet Schwartzenberg	TX	Rheumatology Physician	$2.6M	$0
James Stafford	TX	Radiation Oncology Physician	$1.5M	$0
Psg Surgery Center LLC	TX	Ambulatory Surgical Clinic/Center	$1.3M	$0

Antonio Aragon — Billing Profile & Reimbursement Data

Sign up for Antonio Aragon — Billing Profile & Reimbursement Data policy alerts

Antonio Aragon — Billing Profile & Reimbursement Data

Sign up for Antonio Aragon — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References